Phyto Biologic Pharmaceutics India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -2099.96%
- Net Worth -113.89%
- Total Assets -5.06%
About Phyto Biologic Pharmaceutics India
Phyto Biologic Pharmaceutics India Private Limited (PBPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2019 (Five years and ten months 1 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Kodavali, Lavanya Kodavali, Sanjeeva Chintalapudi, and One other member serve as directors at the Company.
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290AP2019PTC111598
- Company No.
111598
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Phyto Biologic Pharmaceutics India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Kodavali  | Director | 01-Apr-2019 | Current |
| Lavanya Kodavali | Director | 20-Feb-2021 | Current |
| Sanjeeva Chintalapudi | Director | 01-Apr-2019 | Current |
| Chintalapudi Rao | Director | 20-Feb-2021 | Current |
Financial Performance of Phyto Biologic Pharmaceutics India.
Phyto Biologic Pharmaceutics India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2099.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 113.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Phyto Biologic Pharmaceutics India?
In 2022, Phyto Biologic Pharmaceutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eprosoft India Private LimitedSatish Kodavali and Sanjeeva Chintalapudi are mutual person
Kontinental Operations LlpSatish Kodavali is a mutual person
- Anajiva Biopharma Private Limited
Satish Kodavali, Sanjeeva Chintalapudi and 1 more are mutual person
- Genelixir Private Limited
Satish Kodavali is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phyto Biologic Pharmaceutics India?
Unlock and access historical data on people associated with Phyto Biologic Pharmaceutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phyto Biologic Pharmaceutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phyto Biologic Pharmaceutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.